Ramosetron 132907-72-3

Ramosetron is a serotonin 5-HT₃ receptor antagonist for the treatment of nausea and vomiting. Ramosetron is also indicated for a treatment of “diarrhea-predominant irritable bowel syndrome in male. ” In India it is marketed under the brand name of "IBset". It is only licensed for use in Japan and selected Southeast Asian countries. It is commonly sold under the tradename Nasea and in India as Nozia (300 mcg/ml Inj. & 100 mcg Tab. )

read more [+]

Systematic (IUPAC) name:	(1-methyl-1H-indol-3-yl)[(5R)-4,5,6,7-tetrahydro-1H-benzimidazol-5-yl]methanone
Ramosetron CAS number:	132907-72-3
ATC code:
PubChem:	108000
DrugBank:
Formula:	C17H17N3O1
Molecular mass:	279.33 g/mol
Ramosetron Assay/Purity:	Typically NLT 98%

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.